Comparison |
| Alternate Manufacturer Number |
| 3696549 | | 2065472 | |
| Alternate Packaging |
CT/10 | CT/10 | | | EA/1 |
| Container Type |
Prefilled Syringe | Single-Dose Vial | Cartridge | Single-Dose Vial | Single-Dose Vial |
| Country of Origin |
United States | France | Unknown | Unknown | United States |
| Generic Drug Code |
17142 | 17150 | 45132 | 17150 | 17150 |
| Generic Drug Name |
Naloxone HCl, Preservative Free | Naloxone HCl, Preservative Free | Naloxone HCl, Preservative Free | Naloxone HCl | Naloxone HCl, Preservative Free |
| Latex Free Indicator |
| | Not Made with Natural Rubber Latex | | |
| NDC Number |
76329336901 | 70069007110 | 00409178269 | 67457029202 | 51662124203 |
| Strength |
1 mg / mL | 0.4 mg / mL | 0.4 mg / mL | 0.4 mg / mL | 0.4 mg / mL |
| Volume |
2 mL | 1 mL | 1 mL | 1 mL | 1 mL |
| Application |
Opiate Antagonist | Opiate Antagonist | Opiate Antagonist | Opiate Antagonist | Opiate Antagonist |
| Dosage Form |
Injection | Injection | Injection | Injection | Injection |
| Product Dating |
McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 90 days |
| Type |
Intramuscular, Intravenous, or Subcutaneous | Intramuscular, Intravenous, or Subcutaneous | Intramuscular, Intravenous, or Subcutaneous | Intramuscular, Intravenous, or Subcutaneous | Intramuscular, Intravenous, or Subcutaneous |
| UNSPSC Code |
51142315 | 51142315 | 51142315 | 51142315 | 51142315 |
| Features and Benefits |
- Generic Equivalent to Narcan®; Evzio™
- Luer-Jet™ needleless syringe
- Color-coded packaging - industry standard color-coding to aid in quick, reliable identification
- Emergency Syringes provided in completely needleless Luer Lock syringes, complies with OSHA's Needlestick Safety and Prevention Act and are compatible with most Luer Activated Systems (includes ICU Medical Clave® Valve)
|
- Naloxone Hydrochloride Injection is indicated for the complete or partial reversal of opioid depression, including respiratory depression, induced by natural and synthetic opioids including methadone, and certain mixed agonist-antagonist analgesics: nalbuphine, pentazocine, butorphanol, and cyclazocine
- Naloxone hydrochloride is also indicated for the diagnosis of suspected or known acute opioid overdosage
- The single-dose solution contains no bacteriostat, antimicrobial agent or added buffer (except for pH adjustment) and is intended for use only as a single-dose injection
- Store at 20° to 25°C (68° to 77°F)
- Protect from light by retaining in the carton until ready for use
- Single-dose glass flip top vial
- 10 vials per carton
|
- 1 mL fill in 2.5 mL Carpuject™ Single-dose cartridge with Luer Lock for the Carpuject™ Syringe System
- All Carpuject™ Luer Lock Glass Syringe (no needle) products require the use of the Carpuject™ holder, list number 02049-02, for administration
|
|
- Naloxone Hydrochloride Injection is indicated for the complete or partial reversal of opioid depression, including respiratory depression, induced by natural and synthetic opioids including methadone, and certain mixed agonist-antagonist analgesics: nalbuphine, pentazocine, butorphanol, and cyclazocine
- Naloxone hydrochloride is also indicated for the diagnosis of suspected or known acute opioid overdosage
- The single-dose solution contains no bacteriostat, antimicrobial agent or added buffer (except for pH adjustment) and is intended for use only as a single-dose injection
- Store at 20° to 25°C (68° to 77°F)
|
